MGX Stock Summary and Trading Ideas (Metagenomi Therapeutics | NASDAQ:MGX)

Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. The company leverages machine learning and artificial intelligence to enhance its signature gene editing systems. MGX-001 is its, wholly-owned development program in hemophilia A, where the company have demonstrated targeted genome editing and durable gene expression from a one-time treatment in non-human primates (NHPs) and an overall profile potentially competitive with best-in-class treatment options. MGX-001 is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia A from a single administration.

Metagenomi Therapeutics trades on the NASDAQ stock market under the symbol MGX.

As of April 17, 2026, MGX stock price climbed to $1.48 with 311,039 million shares trading.

MGX has a beta of 1.80, meaning it tends to be more sensitive to market movements. MGX has a correlation of 0.13 to the broad based SPY ETF.

MGX has a market cap of $55.68 million. This is considered a Micro Cap stock.

Last quarter Metagenomi Therapeutics reported $4 million in Revenue and -$.60 earnings per share. This fell short of revenue expectation by $-4 million and missed earnings estimates by -$.02.

The top ETF exchange traded funds that MGX belongs to (by Net Assets): VTI, VXF, IWC.

MGX has underperformed the market in the last year with a return of -2.6%, while the SPY ETF gained +36.3%. In the last 3 month period, MGX fell short of the market, returning -10.8%, while SPY returned +2.9%. However, in the most recent 2 weeks MGX has outperformed the stock market by returning +9.6%, while SPY returned +8.3%.

MGX support price is $1.39 and resistance is $1.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MGX shares will trade within this expected range on the day.